China is AstraZeneca's second-largest market after the United States, where the company has recently invested heavily under pressure from President Donald Trump.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/8Lx3zDg
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment